Fiduciary Trust’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $201K | Buy |
2,103
+138
| +7% | +$13.2K | ﹤0.01% | 875 |
|
|
2026
Q1 | $204K | Sell |
1,965
-1,245
| -39% | -$141K | ﹤0.01% | 842 |
|
|
2025
Q4 | $324K | Buy |
3,210
+82
| +3% | +$8.9K | ﹤0.01% | 692 |
|
|
2025
Q3 | $386K | Buy |
3,128
+436
| +16% | +$54.1K | ﹤0.01% | 628 |
|
|
2025
Q2 | $323K | Sell |
2,692
-67
| -2% | -$8.94K | ﹤0.01% | 659 |
|
|
2025
Q1 | $406K | Sell |
2,759
-347
| -11% | -$53K | 0.01% | 570 |
|
|
2024
Q4 | $504K | Buy |
3,106
+1,000
| +47% | +$164K | 0.01% | 473 |
|
|
2024
Q3 | $343K | Hold |
2,106
| – | – | ﹤0.01% | 536 |
|
|
2024
Q2 | $287K | Sell |
2,106
-745
| -26% | -$103K | ﹤0.01% | 551 |
|
|
2024
Q1 | $437K | Hold |
2,851
| – | – | 0.01% | 477 |
|
|
2023
Q4 | $407K | Buy |
2,851
+4
| +0.1% | +$533 | 0.01% | 486 |
|
|
2023
Q3 | $373K | Sell |
2,847
-63
| -2% | -$9.57K | 0.01% | 488 |
|
|
2023
Q2 | $463K | Sell |
2,910
-392
| -12% | -$63.2K | 0.01% | 457 |
|
|
2023
Q1 | $523K | Sell |
3,302
-50
| -1% | -$7.5K | 0.01% | 429 |
|
|
2022
Q4 | $470K | Sell |
3,352
-15
| -0.4% | -$2.13K | 0.01% | 457 |
|
|
2022
Q3 | $432K | Sell |
3,367
-800
| -19% | -$115K | 0.01% | 454 |
|
|
2022
Q2 | $587K | Hold |
4,167
| – | – | 0.01% | 425 |
|
|
2022
Q1 | $579K | Sell |
4,167
-355
| -8% | -$54.4K | 0.01% | 448 |
|
|
2021
Q4 | $788K | Sell |
4,522
-47
| -1% | -$7.83K | 0.01% | 386 |
|
|
2021
Q3 | $757K | Sell |
4,569
-279
| -6% | -$48K | 0.01% | 392 |
|
|
2021
Q2 | $872K | Sell |
4,848
-618
| -11% | -$113K | 0.02% | 358 |
|
|
2021
Q1 | $1.05M | Sell |
5,466
-14
| -0.3% | -$2.69K | 0.02% | 323 |
|
|
2020
Q4 | $1.11M | Buy |
5,480
+784
| +17% | +$162K | 0.02% | 307 |
|
|
2020
Q3 | $987K | Sell |
4,696
-351
| -7% | -$78.2K | 0.02% | 295 |
|
|
2020
Q2 | $1.11M | Sell |
5,047
-326
| -6% | -$65.1K | 0.03% | 264 |
|
|
2020
Q1 | $931K | Sell |
5,373
-290
| -5% | -$47.9K | 0.03% | 267 |
|
|
2019
Q4 | $869K | Buy |
5,663
+2,300
| +68% | +$344K | 0.02% | 300 |
|
|
2019
Q3 | $511K | Buy |
3,363
+714
| +27% | +$113K | 0.01% | 366 |
|
|
2019
Q2 | $406K | Buy |
2,649
+675
| +34% | +$103K | 0.01% | 379 |
|
|
2019
Q1 | $317K | Sell |
1,974
-418
| -17% | -$64.8K | 0.01% | 401 |
|
|
2018
Q4 | $369K | Hold |
2,392
| – | – | 0.01% | 360 |
|
|
2018
Q3 | $360K | Buy |
2,392
+18
| +0.8% | +$2.56K | 0.01% | 375 |
|
|
2018
Q2 | $321K | Sell |
2,374
-301
| -11% | -$37.2K | 0.01% | 387 |
|
|
2018
Q1 | $356K | Hold |
2,675
| – | – | 0.01% | 359 |
|
|
2017
Q4 | $398K | Buy |
2,675
+1
| +0% | +$136 | 0.01% | 343 |
|
|
2017
Q3 | $353K | Hold |
2,674
| – | – | 0.01% | 355 |
|
|
2017
Q2 | $356K | Sell |
2,674
-600
| -18% | -$81K | 0.01% | 359 |
|
|
2017
Q1 | $441K | Sell |
3,274
-536
| -14% | -$69.4K | 0.01% | 338 |
|
|
2016
Q4 | $457K | Sell |
3,810
-4,225
| -53% | -$498K | 0.01% | 339 |
|
|
2016
Q3 | $1.01M | Sell |
8,035
-90
| -1% | -$11.8K | 0.03% | 252 |
|
|
2016
Q2 | $1.12M | Buy |
8,125
+3,582
| +79% | +$464K | 0.04% | 238 |
|
|
2016
Q1 | $573K | Hold |
4,543
| – | – | 0.02% | 320 |
|
|
2015
Q4 | $576K | Sell |
4,543
-25
| -0.5% | -$3.1K | 0.02% | 284 |
|
|
2015
Q3 | $527K | Sell |
4,568
-75
| -2% | -$8.42K | 0.02% | 276 |
|
|
2015
Q2 | $483K | Buy |
4,643
+533
| +13% | +$57.5K | 0.02% | 262 |
|
|
2015
Q1 | $454K | Buy |
4,110
+100
| +2% | +$10.9K | 0.02% | 271 |
|
|
2014
Q4 | $418K | Buy |
4,010
+1,605
| +67% | +$160K | 0.02% | 273 |
|
|
2014
Q3 | $231K | Buy |
2,405
+100
| +4% | +$9.04K | 0.01% | 306 |
|
|
2014
Q2 | $210K | Buy |
+2,305
| New | +$206K | 0.01% | 320 |
|
Other funds holding CLX
Fiduciary Trust's CLX Position: Q2 2026 in Review
Fiduciary Trust increased its Clorox (CLX) stake by 7% in Q2 2026, buying an estimated $13.2K and bringing the position to 2,103 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #875.
Fiduciary Trust first reported a position in CLX in Q2 2014 and has held it in 49 quarters since. The position peaked at $1.12M in Q2 2016. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Fiduciary Trust held 2,103 shares of Clorox worth $201K as of Q2 2026.
- Fiduciary Trust bought 138 Clorox shares in Q2 2026, an estimated $13.2K.
- Clorox made up ﹤0.01% of Fiduciary Trust's portfolio in Q2 2026, its #875 holding.
- Fiduciary Trust first reported a position in Clorox in Q2 2014 and has held it in 49 quarters since.
- Fiduciary Trust's Clorox position peaked at $1.12M in Q2 2016.
- 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.